📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Silicon Therapeutics

1.1 - Company Overview

Silicon Therapeutics Logo

Silicon Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of fully integrated drug design, research and development using a physics-driven approach coupled to chemistry and biology R&D, with a pipeline including VTAMA (Tapinarof) for plaque psoriasis; Batoclimab for autoimmune diseases (MG, TED, CIDP, Graves' Disease); IMVT-1402 (Phase 1) subcutaneous injection; Brepocitinib for dermatomyositis and non-infectious uveitis (Phase 3 for some applications); and Namilumab for sarcoidosis (Phase 2).

Products and services

  • VTAMA (Tapinarof): Topical-formulation cream that treats plaque psoriasis in adults, delivering localized dermal administration to manage psoriatic plaques across affected areas
  • Brepocitinib: Small-molecule therapy addressing Dermatomyositis and Non-Infectious Uveitis, in Phase 3 for some applications, developed for treatment across these specified indications
  • Batoclimab: Biologic-class treatment for autoimmune diseases including Myasthenia Gravis, Thyroid Eye Disease, CIDP, and Graves' Disease, developed to address multiple established indications

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Silicon Therapeutics

Trier Health Logo

Trier Health

HQ: United States Website
  • Description: Provider of a smart, trusted and secure platform for digital clinical trial execution, supporting hybrid and 100% decentralized trials, enriching patient-clinician collaboration and patient engagement through analytics and deep AI, featuring VISION Recruit for AI-driven participant matching, outreach and scheduling, and VISION Engage for patient self-screening, self-scheduling, payments and profile management.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Trier Health company profile →
X-Chem Logo

X-Chem

HQ: United States Website
  • Description: Provider of AI-driven small molecule drug discovery solutions, including ArtemisAI to analyze DEL data and predict new binders; DEL screening services across target classes; medicinal chemistry to convert hits into leads; integrated Dynamic Drug Discovery (XD3); HITMiner to expand binder predictions; and LEADChaser to advance DEL outputs through rapid design-test loops.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full X-Chem company profile →
Genuity Science Logo

Genuity Science

HQ: United States Website
  • Description: Provider of clinco-omics data analysis solutions and genomic sequence data for researchers, with a platform for study design, sequencing, storage, interpretation, secondary analysis, and scalable analytics. Offers disease-specific clinical omics datasets (CNS, cardiometabolic, inflammatory), powered datasets, deeply phenotyped whole genomes, longitudinal data, and population-scale expertise applying deep learning to improve patient health using the human genome.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genuity Science company profile →
Simulations Plus Logo

Simulations Plus

HQ: United States Website
  • Description: Provider of ADMET and pharmacometric modeling software, including GastroPlus for absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics across administration routes in humans and animals; ADMET Predictor for compound property prediction; PKPlus for PK/TK analysis and reporting; DDDPlus for simulating in vitro dissolution to predict in vivo performance; DILIsym for drug-induced liver injury modeling; and MonolixSuite for NLME modeling.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Simulations Plus company profile →
Intelligent Pharma Logo

Intelligent Pharma

HQ: Spain Website
  • Description: Provider of computational technologies for drug discovery and related services, offering computational chemistry services to pharmaceutical companies, biotech companies and research institutes; now part of Mind the Byte.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Intelligent Pharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Silicon Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Silicon Therapeutics

2.2 - Growth funds investing in similar companies to Silicon Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Silicon Therapeutics

4.2 - Public trading comparable groups for Silicon Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Silicon Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Silicon Therapeutics

What does Silicon Therapeutics do?

Silicon Therapeutics is a provider of fully integrated drug design, research and development using a physics-driven approach coupled to chemistry and biology R&D, with a pipeline including VTAMA (Tapinarof) for plaque psoriasis; Batoclimab for autoimmune diseases (MG, TED, CIDP, Graves' Disease); IMVT-1402 (Phase 1) subcutaneous injection; Brepocitinib for dermatomyositis and non-infectious uveitis (Phase 3 for some applications); and Namilumab for sarcoidosis (Phase 2).

Who are Silicon Therapeutics's competitors?

Silicon Therapeutics's competitors and similar companies include Trier Health, X-Chem, Genuity Science, Simulations Plus, and Intelligent Pharma.

Where is Silicon Therapeutics headquartered?

Silicon Therapeutics is headquartered in United States.

How many employees does Silicon Therapeutics have?

Silicon Therapeutics has 1,000 employees 🔒.

When was Silicon Therapeutics founded?

Silicon Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Silicon Therapeutics in?

Silicon Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Silicon Therapeutics

Who are the top strategic acquirers in Silicon Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Silicon Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Silicon Therapeutics?

Top strategic M&A buyers groups and sectors for Silicon Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Silicon Therapeutics's sector and industry vertical

Which are the top PE firms investing in Silicon Therapeutics's sector and industry vertical?

Top PE firms investing in Silicon Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Silicon Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Silicon Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Silicon Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Silicon Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Silicon Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Silicon Therapeutics?

The key public trading comparables and valuation benchmarks for Silicon Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Silicon Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Silicon Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Silicon Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Silicon Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Silicon Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Silicon Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Silicon Therapeutics

Launch login modal Launch register modal